Bioreactor Market by Type (Stirred Tank Bioreactor, Airlift Bioreactor, Packed Bed Bioreactor, Fluidized Bed Bioreactor, Photo Bioreactor, Others); by Application (Stem Cells, T Cells, Mammalian Cell, Others); by Regions (North America, Asia Pacific, Europe, the Middle East & Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2015-2021


Report ID : RNR-203851 Category : Biotechnology Published Date : 2018
Publisher : Research-N-Reports Pages : 126 Format : PDF
Bioreactors are fabricated vessels or frameworks that help a biologically dynamic environment, as cells require a particular environment to develop. Typically, they vary in size from liters to cubic meters and are regularly made of stainless steel for the substantial scale generation of therapeutics. In the biopharmaceutical field, smaller glass bioreactors more often intended for R&D work and process advancement scale-up. In the meantime, single-use bioreactors, otherwise called disposable bioreactors, have been discovering extensive research and manufacturing use. Bioreactors can work as a batch, fed-batch, or consistently stirred-tank reactor frameworks.
The Global Bioreactor Market, in terms of revenue, which was esteemed at US$ 565.64 million in 2015, is relied upon to achieve an estimation of US$ 787.57 million by 2021, developing at a CAGR of 6.9% throughout the forecast time frame. The market is segmented on the basis of type into Stirred Tank Bioreactor, Airlift Bioreactor, Packed Bed Bioreactor, Fluidized Bed Bioreactor, Photo Bioreactor, and Others. Representing over XX% of the aggregate share of the market, the Airlift Bioreactor Segment will be the dominant segment of the market amid the forecast period as it holds the largest share of the market. From the application segments studied in the report, the Stem Cells Segment is projected to be dominant throughout the forecast period. 
Rising predominance of chronic diseases and growing biopharmaceutical investments will drive the Worldwide Bioreactor Market Size. Growing demand for therapeutically effective vaccines, product advancement, and favorable government activities to enhance medicinal services infrastructure will additionally stimulate business development. Customized pharmaceuticals are changing the way numerous diseases are distinguished, categorized, and treated. The developing personalized medicine market that includes a focused population base will additionally drive the bioreactor market size. Another manufacturing technologies have been developed to give more customized drug products, for example, 3D bioprinting. The expansion in the adoption of single-use innovations, use of hybrid technologies: single-use and stainless steel, developing ubiquity of single-use bioreactor among biopharmaceutical organizations, and developing biologics are impelling the development of the bioreactors market. In any case, administrative concerns identified with single-use bioreactors, issues in regards to leachable and extractable identified with single-use bags is hampering the development of this market. Besides, extensive scale disposable of plastic derivatives is a developing environmental concern limiting business development.
North America represented a significant share of the Global Bioreactor Market in 2016 and is relied upon to double the growth of the overall market in the coming years. Representing over XX% of the aggregate share of the global market, the regional Market is projected to be the largest market throughout the forecast period and is evaluated to reach $US 600 Million by 2024 owing to the increasing number of biopharmaceutical companies responsible for bringing new medicines to patients and their collaborations with venture capital firms, academic institutions, and patients. Germany Market subsidized to more than 25% of the regional income share inferable from the presence of prime industry players and rising medicinal expenditure in this region. Favorable administrative policies for biopharmaceutical endorsement and technological advancement in bioprocess equipment will impel business development. The Asia-Pacific Market is anticipated to grow at the highest CAGR during the forecast period. Growing population, increasing prevalence of chronic diseases, rising R&D investment, and unmet healthcare needs will stimulate industry growth. China, for instance, is the most preferred destination for leading biopharma companies for the production of biologics and has attracted significant investment in this field.
The report provides both, qualitative and quantitative research of the market, as well as encompasses worthy insights into the rational scenario and favored improvement methods adopted by key contenders. Some of the primary players of the Global Bioreactor Market are Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, BBI-Biotech, Biotron, Cellexus, Fermentec, Finesse, and Zenith among others.
Introduction 
1.1. Market Scope 
1.2. Market Segmentation 
1.3. Methodology 
1.4. Assumptions 
2. Bioreactor Market Snapshot 
2.1. Market Dynamic Snapshot 
2.1.1. Comparative Analysis (Base year v/s. Forecast) 
2.1.2. Geographic Outlook 
3. Qualitative Analysis: Bioreactor Market 
3.1. Introduction 
3.1.1. Product Definition 
3.1.2. Industry Development 
3.2. Market Dynamics 
3.2.1. Drivers 
3.2.2. Restraints 
3.2.3. Opportunities 
4. Global Bioreactor Market Analysis and Forecasts, 2017 - 2025 
4.1. Overview 
4.1.1. Global Bioreactor Market Revenue (US$ Mn) 
4.2. Global Bioreactor Market Revenue (US$ Mn) and Forecasts, By Type 
4.2.1. Stirred Tank Bioreactor 
4.2.1.1. Definition 
4.2.1.2. Market Penetration, 2015 
4.2.1.3. Market Revenue Expected to Increase by 2025 
4.2.1.4. Compound Annual Growth Rate (CAGR) 
4.2.2. Airlift Bioreactor 
4.2.2.1. Definition 
4.2.2.2. Market Penetration, 2015 
4.2.2.3. Market Revenue Expected to Increase by 2025 
4.2.2.4. Compound Annual Growth Rate (CAGR) 
4.2.3. Packed Bed Bioreactor 
4.2.3.1. Definition 
4.2.3.2. Market Penetration, 2015 
4.2.3.3. Market Revenue Expected to Increase by 2025 
4.2.3.4. Compound Annual Growth Rate (CAGR) 
4.2.4. Fluidized Bed Bioreactor 
4.2.4.1. Definition 
4.2.4.2. Market Penetration, 2015 
4.2.4.3. Market Revenue Expected to Increase by 2025 
4.2.4.4. Compound Annual Growth Rate (CAGR) 
4.2.5. Photo Bioreactor 
4.2.5.1. Definition 
4.2.5.2. Market Penetration, 2015 
4.2.5.3. Market Revenue Expected to Increase by 2025 
4.2.5.4. Compound Annual Growth Rate (CAGR) 
4.2.6. Others  
4.2.6.1. Definition 
4.2.6.2. Market Penetration, 2015 
4.2.6.3. Market Revenue Expected to Increase by 2025 
4.2.6.4. Compound Annual Growth Rate (CAGR) 
4.3. Key Segment for Channeling Investments 
4.3.1. By Type 
5. Global Bioreactor Market Analysis and Forecasts, 2017 - 2025 
5.1. Overview 
5.2. Global Bioreactor Market Revenue (US$ Mn) and Forecasts, By Application 
5.2.1. Stem cells 
5.2.1.1. Definition 
5.2.1.2. Market Penetration, 2015 
5.2.1.3. Market Revenue Expected to Increase by 2025 
5.2.1.4. Compound Annual Growth Rate (CAGR) 
5.2.2. T cells 
5.2.2.1. Definition 
5.2.2.2. Market Penetration, 2015 
5.2.2.3. Market Revenue Expected to Increase by 2025 
5.2.2.4. Compound Annual Growth Rate (CAGR) 
5.2.3. Other mammalian cell 
5.2.3.1. Definition 
5.2.3.2. Market Penetration, 2015 
5.2.3.3. Market Revenue Expected to Increase by 2025 
5.2.3.4. Compound Annual Growth Rate (CAGR) 
5.3. Key Segment for Channeling Investments 
5.3.1. By Application 
6. North America Bioreactor Market Analysis and Forecasts, 2017 - 2025 
6.1. Overview 
6.1.1. North America Bioreactor Market Revenue (US$ Mn) 
6.2. North America Bioreactor Market Revenue (US$ Mn) and Forecasts, By Type 
6.2.1. Stirred Tank Bioreactor 
6.2.2. Airlift Bioreactor 
6.2.3. Packed Bed Bioreactor 
6.2.4. Fluidized Bed Bioreactor 
6.2.5. Photo Bioreactor 
6.2.6. Others  
6.3. North America Bioreactor Market Revenue (US$ Mn) and Forecasts, By Application 
6.3.1. Stem cells 
6.3.2. T cells 
6.3.3. Other mammalian cell 
6.4. North America Bioreactor Market Revenue (US$ Mn) and Forecasts, By Country 
6.4.1. U.S. 
6.4.2. Rest of North America 
6.5. Key Segment for channeling Investments 
6.5.1. By Country 
6.5.2. By Type 
6.5.3. By Application 
7. Europe Bioreactor Market Analysis and Forecasts, 2017 - 2025 
7.1. Overview 
7.1.1. Europe Bioreactor Market Revenue (US$ Mn) 
7.2. Europe Bioreactor Market Revenue (US$ Mn) and Forecasts, By Type 
7.2.1. Stirred Tank Bioreactor 
7.2.2. Airlift Bioreactor 
7.2.3. Packed Bed Bioreactor 
7.2.4. Fluidized Bed Bioreactor 
7.2.5. Photo Bioreactor 
7.2.6. Others  
7.3. Europe Bioreactor Market Revenue (US$ Mn) and Forecasts, By Application 
7.3.1. Stem cells 
7.3.2. T cells 
7.3.3. Other mammalian cell 
7.4. Europe Bioreactor Market Revenue (US$ Mn) and Forecasts, By Country 
7.4.1. France 7.4.2. The U.K. 
7.4.3. Spain 
7.4.4. Germany 
7.4.5. Italy 
7.4.6. Rest of Europe 
7.5. Key Segment for channeling Investments 
7.5.1. By Country 
7.5.2. By Type 
7.5.3. By Application 
8. Asia Pacific Bioreactor Market Analysis and Forecasts, 2017 - 2025 
8.1. Overview 
8.1.1. Asia Pacific Bioreactor Market Revenue (US$ Mn) 
8.2. Asia Pacific Bioreactor Market Revenue (US$ Mn) and Forecasts, By Type 
8.2.1. Stirred Tank Bioreactor 
8.2.2. Airlift Bioreactor 
8.2.3. Packed Bed Bioreactor 
8.2.4. Fluidized Bed Bioreactor 
8.2.5. Photo Bioreactor 
8.2.6. Others  
8.3. Asia Pacific Bioreactor Market Revenue (US$ Mn) and Forecasts, By Application 
8.3.1. Stem cells 
8.3.2. T cells 
8.3.3. Other mammalian cell 
8.4. Asia Pacific Bioreactor Market Revenue (US$ Mn) and Forecasts, By Country 
8.4.1. China 
8.4.2. Japan 
8.4.3. India 
8.4.4. Southeast Asia 
8.4.5. Rest of Asia Pacific 
8.5. Key Segment for channeling Investments 
8.5.1. By Country 
8.5.2. By Type 
8.5.3. By Application 
9. Middle East & Africa Bioreactor Market Analysis and Forecasts, 2017 - 2025 
9.1. Overview 
9.1.1. Middle East & Africa Bioreactor Market Revenue (US$ Mn) 
9.2. Middle East & Africa Bioreactor Market Revenue (US$ Mn) and Forecasts, By Type 
9.2.1. Stirred Tank Bioreactor 
9.2.2. Airlift Bioreactor 
9.2.3. Packed Bed Bioreactor 
9.2.4. Fluidized Bed Bioreactor 
9.2.5. Photo Bioreactor 
9.2.6. Others  
9.3. Middle East & Africa Bioreactor Market Revenue (US$ Mn) and Forecasts, By Application 
9.3.1. Stem cells 
9.3.2. T cells 
9.3.3. Other mammalian cell 
9.4. Middle East & Africa Bioreactor Market Revenue (US$ Mn) and Forecasts, By Country 
9.4.1. GCC Countries 
9.4.2. Southern Africa 
9.4.3. Rest of MEA 
9.5. Key Segment for channeling Investments 
9.5.1. By Country 
9.5.2. By Type 
9.5.3. By Application 
10. Latin America Bioreactor Market Analysis and Forecasts, 2017 - 2025 
10.1. Overview 
10.1.1. Latin America Bioreactor Market Revenue (US$ Mn) 
10.2. Latin America Bioreactor Market Revenue (US$ Mn) and Forecasts, By Type 
10.2.1. Stirred Tank Bioreactor 
10.2.2. Airlift Bioreactor 
10.2.3. Packed Bed Bioreactor 
10.2.4. Fluidized Bed Bioreactor 
10.2.5. Photo Bioreactor 
10.2.6. Others  
10.3. Latin America Bioreactor Market Revenue (US$ Mn) and Forecasts, By Application 
10.3.1. Stem cells 
10.3.2. T cells 
10.3.3. Other mammalian cell 
10.4. Latin America Bioreactor Market Revenue (US$ Mn) and Forecasts, By Country 
10.4.1. Brazil 
10.4.2. Rest of Latin America 
10.5. Key Segment for channeling Investments 
10.5.1. By Country 
10.5.2. By Type 
10.5.3. By Application 
11. Competitive Benchmarking 
11.1. Player Positioning Analysis 
11.2. Global Presence and Growth Strategies 
12. Player Profiles 
12.1. Sartorius AG   
12.1.1. Company Details 
12.1.2. Company Overview 
12.1.3. Key Developments 
12.1.4. Product Offerings 
12.1.5. Financial Analysis 
12.1.6. SWOT Analysis 
12.1.7. Business Strategies 
12.2. Merck KGaA 
12.3. Thermo, Fisher Scientific Inc.  
12.4. GE Healthcare   
12.5. Danaher Corporation   
12.6. Eppendorf AG